Your browser doesn't support javascript.
loading
Pharmacokinetics of Camonagrel in experimental animal: rat, rabbit and dog.
Albet, C; Pérez, A; Rozman, E; Sacristan, A; Ortiz, J A.
Afiliación
  • Albet C; Centro de Investigacion Grupo Ferrer, Barcelona, Spain.
Eur J Drug Metab Pharmacokinet ; 23(2): 251-4, 1998.
Article en En | MEDLINE | ID: mdl-9725489
Camonagrel is a novel selective thromboxane synthetase inhibitor. The aim of this study was to determine its main pharmacokinetic parameters in rats, rabbits and dogs after intravenous and oral administration at doses of 10 mg kg(-1). Plasma and urine concentrations of camonagrel were analyzed by HPLC with UV detection. Pharmacokinetics of camonagrel was generally fitted to a two-compartmental model and the values which defined the absorption process were: Cmax = 15.96 microg.ml(-1), Tmax approximately 0.33 h, AUC(0-infinity) (oral) approximately 12.45 microg x h x ml(-1) (rat, n=3 per pont); Cmax approximately 2.04 mg x ml(-1), Tmax approximately 1.50 h, AUC(0-infinity) (oral) approximately 4.85 microg x h x ml(-1) (rabbit, n=3); Cmax approximately 18.60 microg x ml(-1), Tmax approximately 0.44 h, AUC(0-infinity) (oral) approximately 13.40 microg x h x ml(-1) (dog, n=4). The more representative values in the distribution and elimination phase were: protein binding rate approximately 80% in the three species ("in vitro" experiment); t(1/2beta) approximately 0.22 h (rat, i.v.), = 0.28 h (rabbit i.v.) and approximately 0.45 h (dog i.v.); CI approximately 635.73 ml x h(-1) (rat i.v.), approximately 448.26 ml x h(-1) (rabbit i.v.) and approximately 463.8 ml x h(-1) (dog i.v.). The absolute bioavailability of camonagrel was approximately 79.1% in rat, approximately 21.7% in rabbit and approximately 59.3% in dog. Available elimination data in rat indicated that Camonagrel was mainly excreted in urine (approximately 80%) as unchanged drug. An unknown minor metabolite (approximately 10%) was observed only after oral dosing. Finally, the main pharmacokinetic parameters of camonagrel in rats, rabbits and dogs are presented, which allow to define its absorption, distribution and elimination processes in these species.
Asunto(s)
Buscar en Google
Banco de datos: MEDLINE Asunto principal: Fibrinolíticos / Indanos Límite: Animals Idioma: En Revista: Eur J Drug Metab Pharmacokinet Año: 1998 Tipo del documento: Article País de afiliación: España
Buscar en Google
Banco de datos: MEDLINE Asunto principal: Fibrinolíticos / Indanos Límite: Animals Idioma: En Revista: Eur J Drug Metab Pharmacokinet Año: 1998 Tipo del documento: Article País de afiliación: España